Read More Healthcare Industry News Supernus Pharmaceuticals and Indivior target $125m in savings through CNS merger Supernus Pharmaceuticals and Indivior plan a $2.2 billion CNS merger with 11 medicines, $125 million in synergies and a fourth-quarter close. bySoujanya RaviAugust 3, 2026